PBMCs were isolated at day 50 from IP tumor-bearing mice and activated with anti-CD3/CD28 for 24 h, then analyzed by flow cytometry to determine the extent of T-cell activation, and expression of key transcription factors and effector molecules (Supplementary Figure 7A). The gene discussed is CD28; the disease is neoplasm.